We investigated the effect of resveratrol on oxidation damage and variation of antioxidant defences induced by 2-nitropropane (2-NP) in rat liver. 
Introduction
It is well documented that DNA damage induced by reactive oxygen species (ROS) plays an important role in aging and in a number of human pathological processes, such as chronic inflammation, atherosclerosis, diabetes, ischemia-reperfusion injury and cancer [1] [2] [3] [4] [5] . Resveratrol is a natural phenolic compound with free radical scavenging and antioxidant properties [6] [7] [8] [9] . Many studies have demonstrated the anti-inflammatory and anticancer effects of resveratrol in various organs [10] [11] [12] . In addition, Harikumar and Aggarwal [13] reported that resveratrol is capable of binding to numerous macromolecules involved in cell function, such as multidrug resistance proteins, topoisomerase II, aromatase, DNA polymerase, estrogen receptors and tubulin. Resveratrol can also activate various transcription factors (NF-kB, STAT3, β-catenin and PPAR-γ), inhibit many protein kinases, induce antioxidant enzymes [13] and reduce alterations in the protein expression of mitochondria-mediated apoptosis markers [14] . Recently, Tunali-Akbay et al. [15] found that resveratrol protects against methotrexateinduced hepatic injury in rats by reversing the oxidative toxic damage. In addition, has been reported that resveratrol is able to suppress oxidative stress and inflammatory response in rat hepatocarcinogenesis induced by diethylnitrosamine [16] .
A specific nitroalkane, 2-nitropropane (2-NP), used as a constituent of paints and inks and present in tobacco smoke, can cause hepatic damage in humans and animals [17, 18] . The mechanism by which 2-NP induces hepatoxicity is not clearly defined, but since many studies have demonstrated its effect as a potent inducer of oxidative DNA damage in liver tissue, its toxicity is interpreted as a consequence of ROS generation [18, 19] . Thus, 2-NP has been widely used as a model compound for studies of oxidation damage in the liver of rodents [20] [21] [22] .
On the basis of these considerations, the present studies were carried out to determine the effects of resveratrol on 2-NP-induced oxidative stress and apoptotic changes in the rat liver.
Materials and Methods

Animals and Treatments
All experiments were carried out in accordance with the European Communities Council Directive of 24 November 1986 (86/609/EEC) for experimental animal care.
Male Fisher 344 rats (180 -200 g) were purchased from Nossan (Milan, Italy). After their arrival from the supplier, 15 animals were quarantined for 1 week and fed standard lab chow and water, ad libitum. The rats were then randomly divided into three groups of 5 rats each. One group (2-NP + Res) was given resveratrol (50 mg/kg/d body weight) in the diet until the end of the experiment. The dose of resveratrol was selected by taking into account the safety of this compound in animal studies [23] and based on previously reported chemopreventive doses of resveratrol in rodents [24] . A second group was administered only 2-NP and the third group served as control (C). Taking into account that approximately 15 g of diet were consumed by each rat every day, we added resveratrol in the diet (600 ppm) in order to reach a dose of 50 mg/kg/day. After 14 days, 100 mg/kg of 2-NP in saline supplemented with 0.1 % Tween80 was injected i.p. into 2 groups of animals while the control group (C) was treated with the vehicle alone. Animals of all 3 groups were killed by decapitation 15 h after 2-NP injection. The liver and colon were excised and frozen at -80˚C. Liver and colon tissues were homogenized in 50 mM phosphate buffered solution (PBS) containing 0.1M dithiothreitol and then centrifuged at 4˚C for 20 min at 2000 × g. Pellets were used for 8-oxo-7,8-dihydro-2'-deoxyguanosine (8-oxodGuo) determination, while malonyldialdehyde (MDA), protein carbonyl residues, superoxide dismutase (SOD), xanthine oxidase (XO) were measured in the liver and colon mucosa supernatants. In addition, in the liver supernatant reduced (GSH) and oxidized glutathione (GSSG), were also measured.
Materials
2-NP, resveratrol and all chemicals were purchased from Sigma, Milan, Italy. HPLC Shimadzu (10 AD). Coulochem II electrochemical detector (ESA). UV (Perkin Elmer) detector.
8-Oxodguo Assay
Liver pellets were re-suspended and DNA was isolated with the method recommended by ESCODD group [25] . Purified DNA was hydrolysed with P1 nuclease (14 IU) and alkaline phosphatase (10 IU). The hydrolysed mixture was filtered using Micropure-EZ enzyme remover (Amicon, MA, USA) and 50 µl were injected into an HPLC apparatus. The nucleosides were separated using a C18 reverse-phase column (Supelco, 5 µm, I.D. 0.46 × 25 cm). The 8-oxodGuo and 2dG levels in DNA were measured using an ESA Coulochem II electrochemical detector in line with a UV detector as previously described [26] .
Carbonyl Residues Assessment
Carbonyl residues were determined by the method of Correa-Salde and Albesa [27] . Liver supernatant (0.35 ml) was treated for 1 h with 1 ml of 0.1% dinitrophenylhydrazine in 2 M HCl and precipitated with 10% trichloroacetic acid before being centrifuged for 20 min at 10,000 x g. The pellets were extracted with 1 ml of an ethanol:ethyl acetate mixture (1:1) three times and then dissolved in 2 ml of 6 M guanidine HCl in 20 mM potassium phosphate buffer (PBS) pH 7.5. The solutions were incubated at 37˚C for 30 min and insoluble debris was removed by centrifugation. The absorbance was measured at 364 nm.
MDA Determination
MDA was determined after derivatization with 2,4-dinitrophenylhydrazine (DNPH) as described by Mateos et al. [28] . Briefly, 50 µl of 6M NaOH were added to an aliquot of 500 µl of liver supernatant. Alkaline hydrolysis of protein bound MDA was achieved by incubating this mixture in a 60˚C water bath for 30 min and protein precipitated with 250 µl of 30% (v/v) trichloroacetic acid. A 250 µl volume of supernatant was mixed with 25 µl of 5 mM DNPH in 2M hydrochloric acid. Finally, this reaction mixture was incubated for 30 min at room temperature protected from light. An aliquot of 100 µl was injected into a Shimadzu LC-10AD HPLC system with a Waters Spherisorb RP-18 column (4.6 mm × 150 mm, ODS 25 um, Supelco).
Samples were eluted with a mixture of 0.2% (v/v) acetic acid and acetonitrile (62:38, v/v) at a flow rate of 0.8 ml/min . Chromatograms were acquired at 310 nm. The calibration curve, prepared by diluting a standard solution of tetraethoxypropane (TEP), was reported in 
SOD Activity
SOD was determined in the liver supernatant using the nitroblue tetrazolium (NBT) reaction [29] . The reaction mixture, containing 0.2 ml of liver supernatant, 2.4 ml of 50 mM Na 2 CO 3 , 0.1 ml of 3 mM EDTA, 0.1 ml of 3 mM xanthine, 0.1 ml of 0.8 mM NBT and 0.1 ml of XO (140 mU/ml initial concentration), was incubated for 30 min at 24˚C. The inhibition of NBT reduction in each sample was determined spectrophotometrically at 470 nm. SOD content, expressed as U/mg protein, was evaluated by relating to inhibition by the SOD standard measured at the same time.
XO Activity
XO was determined in the liver supernatant according to Corte and Stirpe [30] . XO activity, expressed as U/mg protein, was assayed by measuring uric acid production at 280 nm.
Determination of GSH and GSSG
The procedure was performed following the method by Cereser et al. [31] with few modifications. Briefly, 100 µl of liver supernatant were diluted by addition of 500 mM sodium phosphate pH 7; 100 µl of this solution was mixed with 100 µl ortho-pthalaldehyde (OPA) (5 mg/ml) and 100 µl was injected into an HPLC system to determine reduced GSH; total glutathione (GSHt) was evaluated by performing a reduction step of GSSG with dithiotreitol. The GSSG concentration was obtained by subtraction of the GSH from the GSHt. Chromatography of GSH and GSHt after their derivatization with OPA was accomplished using isocratic elution in a Discovery C18 (150mm × 4mm i.d.) 5µm analytical column (Supelco, USA) at 37˚C. The mobile phase consisted of 8% acetonitrile in 50 mM sodium acetate pH 6.2. The flow rate was set at 1 ml/min. An optimum response of the fluorescent derivate was observed when the excitation and emission wavelengths in the detector were set at 350 and 420 nm, respectively.
Oxoguanine Glycosylase (OGG 1) mRNA Levels in the Liver
Total liver RNA was extracted using the RNeasy Midi kit with DNase step (Qiagen, Milan, Italy), according to the manufacturer's instructions. For first-strand cDNA synthesis, 1 mg of total RNA from each sample was reverse-transcribed using 100 units of RT Super-Script II (Life Technologies, San Giuliano, Milan, Italy) and 1X random hexamers (Roche Diagnostics, Monza, Italy). The primers used were: OGG1 (NM_030870) F 5'-CAC TTC CAA AGT GTG GCT CA-3; R 5'-CAT AAG AGG CCA CTC GAA GC-3' (346 bp); β-actin F 5'-ACC ACA GCT GAC AGG GAA ATC G-3'; R 5'-AGA GGT CTT TAC GGA TGT CAA CG-3' (281 bp). The PCR reactions were carried out in a 25 µL volume containing 1X PCR buffer, 1.2 mmol/L MgCl 2 , 0.5 mmol/L dNTPs, 1.6 µmol/L of OGG1 primers, 0.04 µmol/L of the b-actin primers and 1.25 U of Taq polymerase (Sigma-Aldrich, Italy). The PCR conditions were: 95˚C for 7 min and then 35 cycles at 95˚C for 30 sec, 60˚C for 30 sec and 72˚C for 55 sec. PCRs were performed in a Perkin Elmer 9700 thermal cycler (Perkin Elmer, Foster City, CA, USA). The PCR products were separated on 1.6% agarose gel and visualized by ethidium bromide staining. Gel images were captured by a digital photocamera (UviDoc) and the intensity of the bands was analysed with Quantity-One software (BioRad, Segrate, Milan, Italy). The relative amount of mRNA in the samples was normalised using b-actin co-amplified as internal standard [32] .
Western-Blot
Liver samples were homogenized in lysis buffer of the following composition (in mM): 50 Tris·HCl pH 7.5, 1 EDTA, 150 NaCl, 1 Na 3 VO 4 , 10 NaF and complete protease inhibitor cocktail tablet (Sigma-Aldrich, St. Louis, MO, USA). The homogenate was centrifuged (1000 × g) for 10 min at 4˚C to remove cell debris. Proteins were then separated on a 12% (w/vol) SDS-PAGE, transferred to PVDF membranes, blocked with Blocker Non-Fat Dry Milk (Bio-Rad, Richmond, CA) and probed with mouse anti-rabbit caspase-3 polyclonal antibodies (1:1000 dilution; St. Cruz Biotechnology Inc., CA, USA) or with polyclonal anti-rabbit glyceraldehyde-3-phosphate dehydrogenase (GAPDH; 1:1000 dilution; Sigma-Aldrich, St. Louis, MO, USA) overnight at 4˚C. After extensive washings, a monoclonal goat anti-rabbit peroxidase conjugated antibody was added (1:10000 dilution; Sigma-Aldrich, St. Louis, MO, USA) and immu- nodetected bands were visualized by ECL. Densitometric analysis of autoradiographic bands referred to GAPDH expression, taking into account the size and area of the band (Scion software Image Corp).
Statistical Analysis
Parametric variables were compared using the t-test. Correlations were performed using linear regression analysis, and the significance level was considered as p < 0.05. The statistical analysis was carried out using the Stata statistical package (Stata, Collage Station, TX).
Results
To evaluate the effect of resveratrol on oxidation damage in the rat liver, we used 2-NP to induce oxidative DNA damage.
Administration by i.p. of 100 mg/kg 2-NP generated ROS and considerably increased 8-oxodGuo in the rat liver DNA, 15 h after injection (Figure 2) . Pre-treatment of rats with resveratrol (50 mg/kg/d) for 14 days before 2-NP administration restored 8-oxodGuo in DNA to levels similar to those of controls (Figure 2) . Although the average protein oxidation measured as carbonyl residues was not significantly modified by 2-NP injection (Table  1) , a correlation between carbonyl residues and 8-oxodGuo levels in the liver of rats treated with 2-NP was found (Figure 3) .
2-NP induced an increase (about 2.5-fold) in SOD activity and a slight, but significant increase in XO activity, a pro-oxidant enzyme; however, in the group treated with resveratrol, SOD and XO levels were similar to controls ( Table 1) . On the contrary, lipoperoxidation, measured as MDA levels, was similar in the three groups ( Table 1 ). An inverse correlation existed between MDA and SOD activity in rats from 2-NP group (Figure 4) .
We examined whether 2-NP injection affected the ex- pression of the 8-oxoguanine-DNA glycosylase (OGG-1) which catalyses the removal of mutagenic 8-oxo-7,8-dihydroguanine from DNA. We observed a borderline significant increased expression of the OGG1 gene in the rat liver of 2-NP group (p = 0.06) whereas, rats pre-treated with resveratrol showed a hepatic OGG1 expression similar to that observed in controls ( Table 1 and Figure  5 ). Treatment with 2-NP also significantly reduced GSH/ GSSG ratio (75%) in comparison to controls and this change was partially reversed by resveratrol (Figure 6 ). An inverse correlation existed between the GSH/GSSG ratio and 8-oxodGuo in 2-NP group (Figure 7) . Figure 8 shows Western blot analysis for the 2-NP induced alterations and preventive response of resveratrol on the expression of specific marker protein (activated caspase-3) of apoptosis in the rat liver. Animals responded to 2-NP (100 mg/kg) injection by up-regulating the activation of caspase-3 (about 40-fold) in comparison to controls. Pre-treatment with resveratrol (50 mg/kg/d) for 14 days before the 2-NP injection significantly reduced the activation of caspase-3 (Figure 8) .
We saw no oxidation damage on the colon mucosa after 2-NP, in fact, all measured markers of oxidative stress and antioxidant response were similar to those of controls ( Table 2 ).
Discussions
Resveratrol is a phenolic compound with free-radical scavenging and antioxidant properties [8, 9] . Our data show that treatment with resveratrol before 2-NP injection significantly reduces oxidative stress and apoptosis in the liver of rats.
These results are consistent with previous studies demonstrating resveratrol does prevent the increased of 8-oxodGuo in kidney DNA induced by toxic compounds [33] and the increased excretion of 8-oxodGuo in urine of genetically hypertensive rats [34] . Recently, resveratrol has also been shown to ameliorate hepatic injury in rats with severe acute pancreatitis, suppress oxidative stress and inflammatory response in diethylnitrosamineinitiated rat hepatocarcinogenesis [9, 16] and protect PC12 cells against 4-hydroxynonenal induced oxidative stress-mediated apoptotic neurodegeneration [17] . It has been suggested that 2-NP metabolism in the liver does produce a variety of metabolites, including the anionic tautomer propane 2-nitrate, nitric oxide, lipid hydroperoxide radicals and nitrogen dioxide radicals, capable of causing cellular damage [33] [34] [35] . In particularly, as we and others reported, 2-NP at dose of 100 mg/kg is able to induce a powerful oxidative DNA damage in the rat liver tissue [18, 20, 21, 36] . Resveratrol does seem to be able to protect cells against oxidative injury through different mechanisms [37, 38] . Leonard et al., [39] have showed that resveratrol did scavenge the O 2 -radical produced by cells after exposure to Cr(VI) and observed an inhibition of DNA damage due to OH · radicals produced by the Fenton reaction [39] . The protective effects of resveratrol on oxidative DNA damage in vivoinduced found in our experiments confirm the radical scavenger ability of resveratrol earlier found in vitro and in ex vivo assays [40, 41] . In addition, the normalization of XO activity induced by resveratrol in our experiments does suggest that a reduced superoxide generation through XO may explain another mechanism by which resveratrol exercts a protective effect, in line with results previously presented by Ates et al. [42] in traumatic brain injury. We also found that resveratrol tended to normalize the GSH/GSSG ratio which was inversely correlated with the variations of 8-oxodGuo in DNA. This last observation does suggest that the reduction of oxidative DNA damage operated by resveratrol might be possibly due, amongst other causes, to an attenuation of 2-NP-mediated GSH depletion, as reported by Kode et al., [43] , who demonstrated that resveratrol does protect against cigarette smoke-mediated oxidative stress in human lung epithelial cells inducing GSH synthesis.
Lipoperoxidation measured as MDA levels, in the liver of rats killed 15 h after 100 mg/kg 2-NP, did not undergo any significant change in our experiments. On the contrary, an increase of MDA was reported by Wilhelm in rats who had been administered with 120 mg/kg 2-NP. Lipoperoxidation products (MDA + 4-hydroxyalkenals) was found by others in rat liver treated with 2-NP at 165 mg/kg [44] and at our dose of 100 mg/kg but measured 48 h after 2-NP administration [21] . Therefore, the lack of lipoperoxidation in our experiments may have been cause by variations in dose and sampling times. However, in our experiments 2-NP did enhance SOD activity, probably as an antioxidant response. Consequently, lipoperoxidation did not occur, as suggested by the inverse correlation found between MDA and SOD in 2-NP rat group. We suppose that pre-treatment with resveratrol protecting liver by injury it is capable of blocking anti-oxidant defensive response, consequently, SOD activity in 2-NP+Res group is similar to that of controls. Borges et al. [21] did not observe a change in SOD activity in the liver of rats sacrificed 48h after 2-NP injection. Once more the difference in lag time might explain such discrepancy. Like change in SOD activity, a tendency (p = 0.06) of increase in the expression of the OGG1 gene, absent in the 2-NP rat group treated with resveratrol, was detected in the liver of 2-NP rats, indicating that 2-NP injection may induce a protective response also through an increasing of DNA repair pathway. Although higher OGG1 gene expression and SOD activity were found in the liver of 2-NP rats than controls, 8-oxodGuo levels were enhanced in their liver DNA. On the contrary, 2-NP+Res rats had 8-oxodGuo levels similar to those found in controls suggesting that resveratrol is capable to reduce oxidation damage 2-NP-induced in the liver DNA. The induction of oxidative DNA damage 15 h after 100 mg/kg 2-NP injection was accompanied with a relevant activation of caspase-3, so informing of an induced apoptosis. Resveratrol at the dose of 50 mg/kg/day for 14 days before 2-NP injection was able to almost prevent completely (98%) the induction of apoptosis and to reduce oxidative DNA damage at levels similar to those detected in the liver of control rats. This observation was consistent with the results obtained by Sha et al., [9] in rats with acute hepatic injury who found that resveratrol (10 mg/kg), injected through the Vena Dorsalis of the penis ameliorated hepatic injury, via the mitochondrial pathway, in rats with chemically induced acute pancreatitis [9] . Recently, similar observations were reported by Siddiqui et al., [16] in PC12 cells exposed for 2 h to 4-hydroxynone-nal using resveratrol at 25 µM concentration.
Coming to a conclusion, our results prove oxidative DNA damage and apoptosis to be the main mechanisms of death cell in a model of chemically induced acute hepatic injury. At this early stage of damaging processes, resveratrol at dose of 50 mg/kg/day administered 14 days long can ameliorate hepatic injury by its antioxidant and scavenging properties, through a reduction of XO activity, a partial restoration of GSH/GSSG ratio in addition to its capacity to inhibit apoptosis.
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